Section 202 – Medical cannabis caregiver card — Registration — Renewal — Revocation.
Effective 3/23/2022 26-61a-202. Medical cannabis caregiver card — Registration — Renewal — Revocation. (1) (a) A cardholder described in Section 26-61a-201 may designate, through the state central patient portal, up to two individuals, or an individual and a facility in accordance with Subsection (1)(b), to serve as a designated caregiver for the cardholder. (b) (i) […]
Section 203 – Designated caregiver — Guardian — Criminal background check.
Effective 9/23/2019 26-61a-203. Designated caregiver — Guardian — Criminal background check. (1) Except for an applicant reapplying for a medical cannabis card within less than one year after the expiration of the applicant’s previous medical cannabis card, each applicant for a medical cannabis guardian card under Section 26-61a-201 or a medical cannabis caregiver card under […]
Section 103 – Electronic verification system.
Effective 3/23/2022 26-61a-103. Electronic verification system. (1) The Department of Agriculture and Food, the department, the Department of Public Safety, and the Division of Technology Services shall: (a) enter into a memorandum of understanding in order to determine the function and operation of the state electronic verification system in accordance with Subsection (2); (b) coordinate […]
Section 104 – Qualifying condition.
Effective 3/24/2022 26-61a-104. Qualifying condition. (1) By designating a particular condition under Subsection (2) for which the use of medical cannabis to treat symptoms is decriminalized, the Legislature does not conclusively state that: (a) current scientific evidence clearly supports the efficacy of a medical cannabis treatment for the condition; or (b) a medical cannabis treatment […]
Section 105 – Compassionate Use Board.
Effective 3/24/2022 26-61a-105. Compassionate Use Board. (1) (a) The department shall establish a Compassionate Use Board consisting of: (i) seven qualified medical providers that the executive director appoints and the Senate confirms: (A) who are knowledgeable about the medicinal use of cannabis; (B) who are physicians licensed under Title 58, Chapter 67, Utah Medical Practice […]
Section 106 – Qualified medical provider registration — Continuing education — Treatment recommendation — Limited medical provider.
Effective 3/24/2022 26-61a-106. Qualified medical provider registration — Continuing education — Treatment recommendation — Limited medical provider. (1) (a) (i) Except as provided in Subsection (1)(b), an individual may not recommend a medical cannabis treatment unless the department registers the individual as a qualified medical provider in accordance with this section. (ii) Notwithstanding Subsection (1)(a)(i), […]
Section 107 – Standard of care — Physicians and pharmacists not liable — No private right of action.
Effective 3/17/2021 26-61a-107. Standard of care — Physicians and pharmacists not liable — No private right of action. (1) An individual described in Subsection (2) is not subject to the following solely for violating a federal law or regulation that would otherwise prohibit recommending, prescribing, or dispensing medical cannabis, a medical cannabis product, or a […]
Section 108 – Agreement with a tribe.
Effective 12/3/2018 26-61a-108. Agreement with a tribe. (1) As used in this section, “tribe” means a federally recognized Indian tribe or Indian band. (2) (a) In accordance with this section, the governor may enter into an agreement with a tribe to allow for the operation of a medical cannabis pharmacy on tribal land located within […]
Section 109 – Qualified Patient Enterprise Fund — Creation — Revenue neutrality.
Effective 9/23/2019 26-61a-109. Qualified Patient Enterprise Fund — Creation — Revenue neutrality. (1) There is created an enterprise fund known as the “Qualified Patient Enterprise Fund.” (2) The fund created in this section is funded from: (a) money the department deposits into the fund under this chapter; (b) appropriations the Legislature makes to the fund; […]
Section 202 – Duties.
Effective 5/4/2022 26-61-202. Duties. (1) The board shall review any available scientific research related to the human use of cannabis, a cannabinoid product, or an expanded cannabinoid product that: (a) was conducted under a study approved by an IRB; (b) was conducted or approved by the federal government; or (c) (i) was conducted in another […]